CTOs on the Move

Cleveland Biolabs

www.cbiolabs.com

 
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cbiolabs.com
  • 73 High St
    Buffalo, NY USA 14203
  • Phone: 716.849.6810
  • Fax: 716.849.6820

Executives

Name Title Contact Details

Funding

Cleveland Biolabs raised $25 on 07/16/2015
Cleveland Biolabs raised $10.5M on 08/16/2018
Cleveland Biolabs raised $14M on 02/19/2021

Similar Companies

Med-Response Inc

Med-Response Inc is a Bluefield, WV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beacon Specialized Living

Beacon Specialized Living is a company that provides assisted living facilities and behavioral healthcare services for developmentally disabled, mentally ill, and autistic adults.

Pacific Companies

Pacific Companies is a Anchorage, AK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Relievant Medsystems

Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous Nerve Ablation System leverages proprietary instruments and methods to disable this nerve.

Excredsys

Excredsys is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.